COMMUNIQUÉS West-GlobeNewswire

FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.
29/04/2026
Agency to Continue Rigorous Oversight and Additional Testing White Oak, Md., April 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced results from the largest and most rigorous [...]
Availabilty of 2026 AGM preparatory documents
29/04/2026
Press Release Paris, 29 April, 2026 Combined General Meeting of May 27, 2026 Availability of preparatory documents EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 27 [...]
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
29/04/2026
Novel procedure combines image-guided tumor cryolysis with intratumoral immunotherapy infusion, with early clinical findings in metastatic prostate cancer FORT LAUDERDALE, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- [...]
Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - Belén Garijo nommée administratrice et Directrice générale de Sanofi
29/04/2026
Assemblée Générale Annuelle du 29 avril 2026 Belén Garijo nommée administratrice et Directrice générale de Sanofi Paris, le 29 avril 2026 . L’Assemblée Générale Mixte des actionnaires de Sanofi s’est réunie le 29 avril [...]
Beacon Therapeutics Announces Presentations at the ARVO 2026 Annual Meeting
29/04/2026
LONDON and CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission to save and [...]
NADP advocates greater access to care through dental coverage
29/04/2026
Association represents dental benefits industry at Advocacy in Action DALLAS, April 29, 2026 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) underscored its commitment to expanding access to dental [...]
Carbios files its 2025 Universal Registration Document
29/04/2026
Clermont-Ferrand (France), 29 April 2026 (6:00 pm CEST). Carbios (Euronext Growth Paris: ALCRB) announces to its shareholders and the financial community that its 2025 Universal Registration Document, including: the [...]
EHS Opens Walsh Ambulatory Pavilion, Expanding Access to Advanced Outpatient Care
29/04/2026
FAR ROCKAWAY, N.Y., April 29, 2026 (GLOBE NEWSWIRE) -- Episcopal Health Services (EHS) proudly announces the opening of the Walsh Ambulatory Pavilion, a 65,000-square-foot, state-of-the-art outpatient facility located [...]
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
29/04/2026
Annual General Meeting of April 29, 2026 Belén Garijo appointed as Director and Chief Executive Officer of Sanofi Paris, April 29, 2026. Sanofi's Mixed General Meeting of Shareholders convened on April 29, 2026, under [...]
Modalité de mise à disposition des documents préparatoires à l'AG 2026
29/04/2026
Communiqué de presse Paris, le 29 avril 2026 Assemblée Générale du 27 mai 2026 Modalités de mise à disposition des documents préparatoires Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée générale [...]
Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)
29/04/2026
Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:30am CDT AUSTIN, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Cristcot, a clinical-stage pharmaceutical [...]
CARBIOS annonce la mise à disposition de son Document d’enregistrement universel 2025
29/04/2026
Clermont-Ferrand (France), 29 avril 2026 (18h00 CEST). Carbios (Euronext Growth Paris : ALCRB) informe ses actionnaires et l’ensemble de la communauté financière que son Document d’enregistrement universel 2025, [...]
EUROBIO SCIENTIFIC : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
29/04/2026
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Paris, le 29 avril 2026 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro pour la transplantation [...]
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025
29/04/2026
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025 Pièce jointe EBS - RFA 2025
U.S. News & World Report Announces "Best of" 2026 Ratings for Legend Senior Living® Residences
29/04/2026
WICHITA, Kan., April 29, 2026 (GLOBE NEWSWIRE) -- U.S. News & World Report has named 27 residences of Legend Senior Living among its "Best of" for 2026 in their respective categories and 11 additional Legend [...]
BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026
29/04/2026
BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today [...]
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
29/04/2026
Presentation will showcase recent data from multiple clinical studies evaluating dual-targeting CD19/BCMA CAR-T therapy candidate TPST-2003 Results support clinical benefit of parallel-structure dual-targeting CAR [...]
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
29/04/2026
Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026 RICHMOND, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a [...]
Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting
29/04/2026
LONDON and CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission to save and [...]

Pages